Koppevacciner giver Bavarian Nordic milliardomsætning

I årets første kvartal omsatte Bavarian Nordic for 1,25 milliarder kroner mod 320 millioner året før.

24 May 2022, Bavaria, Planegg: The logo of the biotechnology company Bavarian Nordic is seen on a sign on a company building. Bavarian Nordic is the manufacturer of Imvanex, a vaccine against smallpox. Photo by: Sven Hoppe/picture-alliance/dpa/AP Images Fold sammen
Læs mere
Foto: Sven Hoppe